ICAM3: Difference between revisions
CSV import |
CSV import |
||
| Line 28: | Line 28: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 14:31, 17 March 2025
ICAM3 (InterCellular Adhesion Molecule 3) is a protein that in humans is encoded by the ICAM3 gene. It is a member of the intercellular adhesion molecule (ICAM) family of immunoglobulin superfamily. ICAM3 plays a crucial role in the immune system, particularly in the process of leukocyte adhesion and migration.
Structure[edit]
ICAM3 is a type I transmembrane glycoprotein with a molecular weight of approximately 110 kDa. It consists of five immunoglobulin-like domains, a transmembrane region, and a short cytoplasmic tail. The extracellular portion of ICAM3 contains binding sites for lymphocyte function-associated antigen 1 (LFA-1), a protein involved in leukocyte adhesion.
Function[edit]
ICAM3 is primarily expressed on leukocytes and is involved in various immune responses. It facilitates the adhesion and migration of leukocytes by interacting with LFA-1. This interaction is crucial for the immune response, as it allows leukocytes to travel to the site of infection or inflammation.
ICAM3 also plays a role in T cell activation. It is involved in the initial interaction between T cells and dendritic cells, which is a critical step in the immune response.
Clinical Significance[edit]
Alterations in the expression or function of ICAM3 can lead to various health conditions. For example, reduced levels of ICAM3 have been associated with rheumatoid arthritis, a chronic inflammatory disorder. Additionally, ICAM3 has been implicated in the progression of certain types of cancer, as it can promote tumor cell migration and invasion.
See Also[edit]
References[edit]
<references/>